文献速递肝病

代谢型谷氨酸受体5在自然杀伤细胞中通过细胞毒性减轻肝纤维化

Metabotropic Glutamate Receptor 5 in Natural Killer Cells Attenuates Liver Fibrosis by Exerting Cytotoxicity to Activated Stellate Cells.
PubMed 文献 · Hepatology · 2021-07-29

该研究探讨了代谢型谷氨酸受体5(mGluR5)在自然杀伤(NK)细胞中减轻肝纤维化的机制。在 mice 和人类中,mGluR5 激活通过增加细胞毒性和干扰素-γ(IFN-γ)产生来减轻肝纤维化。mGluR5 可能作为肝纤维化的潜在治疗靶点。

要点

  • mGluR5 在 NK 细胞中激活可减轻小鼠肝纤维化。
  • mGluR5 激活增强 NK 细胞对活化肝星状细胞的细胞毒性。
  • 晚期肝纤维化中 HSCs 摄取谷氨酸增多,逃避 NK 细胞毒性。

核心结论

  • mGluR5 通过增强 NK 细胞细胞毒性在减轻肝纤维化中起重要作用,可能作为潜在治疗靶点。

研究设计与样本

  • 研究使用 mGluR5 敲除小鼠、NK 细胞特异性 mGluR5 敲除小鼠,以及体外和人类 NK 细胞实验。
  • 小鼠模型包括 2 周注射四氯化碳(CCl4)或 5 周蛋氨酸和胆碱缺乏饮食诱导肝纤维化。

主要发现

  • 在 mGluR5 敲除小鼠中,CCl4 或缺乏饮食诱导的肝纤维化更严重,NK 细胞频率显著降低。
  • NK 细胞特异性 mGluR5 敲除小鼠 CCl4 诱导的肝纤维化加重,IFN-γ 产生减少。
  • 体外 mGluR5 激活通过 MEK/ERK 通路增加 Ifng、Prf1 和 Klrk1 表达及 IFN-γ 产生,增强对活化 HSCs 的细胞毒性。
  • 活化 HSCs 摄取谷氨酸增加,导致细胞外谷氨酸短缺,减少 NK 细胞 mGluR5 刺激,使 HSCs 逃避 NK 细胞毒性。
  • 体内药理学激活 mGluR5 加速 CCl4 诱导的肝纤维化消退;人类健康供体 NK 细胞 mGluR5 激活增强细胞毒性,但肝硬化患者 NK 细胞 mGluR5 表达显著降低,激活无效。

临床怎么用

  • mGluR5 激活可能作为肝纤维化的治疗策略,但需考虑肝硬化患者 NK 细胞 mGluR5 表达降低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The important roles of glutamate and metabotropic glutamate receptor 5 (mGluR5) in HSCs have recently been reported in various liver diseases; however, the mechanism linking the glutamine/glutamate metabolism and mGluR5 in liver fibrosis remains unclear. Here, we report that mGluR5 activation in natural killer (NK) cells attenuates liver fibrosis through increased cytotoxicity and interferon-γ (IFN-γ) production in both mice and humans. APPROACH AND RESULTS: Following 2-week injection of carbon tetrachloride (CCl4 ) or 5-week methionine-deficient and choline-deficient diet, liver fibrosis was more aggravated in mGluR5 knockout mice with significantly decreased frequency of NK cells compared with wild-type mice. Consistently, NK cell-specific mGluR5 knockout mice had aggravated CCl4 -induced liver fibrosis with decreased production of IFN-γ. Conversely, in vitro activation of mGluR5 in NK cells significantly increased the expression of anti-fibrosis-related genes including Ifng, Prf1 (perforin), and Klrk1 (killer cell lectin like receptor K1) and the production of IFN-γ through the mitogen-activated extracellular signal-regulated kinase/extracellular signal-related kinase pathway, contributing to the increased cytotoxicity against activated HSCs. However, we found that the uptake of glutamate was increased in activated HSCs, resulting in shortage of extracellular glutamate and reduced stimulation of mGluR5 in NK cells. Consequently, this could enable HSCs to evade NK cell cytotoxicity in advanced liver fibrosis. In vivo, pharmacologic activation of mGluR5 accelerated CCl4 -induced liver fibrosis regression by restoring NK cell cytotoxicity. In humans, mGluR5 activation enhanced the cytotoxicity of NK cells isolated from healthy donors, but not from patients with cirrhosis with significantly reduced mGluR5 expression in NK cells. CONCLUSIONS: mGluR5 plays important roles in attenuating liver fibrosis by augmenting NK cell cytotoxicity, which could be used as a potential therapeutic target for liver fibrosis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Choi WM, Ryu T, Lee JH, et al. Metabotropic Glutamate Receptor 5 in Natural Killer Cells Attenuates Liver Fibrosis by Exerting Cytotoxicity to Activated Stellate Cells. Hepatology. 2021. PMID: 33932306. doi:10.1002/hep.31875

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。